Draig Therapeutics
Latest round
- Series B
Last raised
- Jul 2026
Total raised
- $210M
Investors
- 12
About Draig Therapeutics
Based in Cardiff, UK, Draig Therapeutics Limited is a biotechnology company founded in 2024 by Simon Ward and John Atack. The company specializes in developing innovative neuromodulators for neuropsychiatric disorders, with a primary focus on Major Depressive Disorder (MDD). Draig Therapeutics focuses on the development of next-generation neuromodulators aimed at treating neuropsychiatric disorders, particularly Major Depressive Disorder (MDD). Their lead product, DT-101, is a next-generation AMPA receptor positive allosteric modulator (PAM) designed to restore synaptic balance by modulating crucial neurotransmitters Glutamate and GABA, alleviating MDD symptoms and potentially addressing other neuropsychiatric disorders. Additionally, Draig is advancing a pipeline of selective GABA A receptor modulators for various conditions such as anxiety disorders, bipolar disorder, schizophrenia, and PTSD, targeting a global market for innovative treatment options. The company's anticipated revenue model is centered on strategic partnerships, licensing opportunities, and future commercialization agreements. As its pipeline advances through clinical development, Draig Therapeutics expects to collaborate with healthcare providers, pharmaceutical companies, and research institutions to support clinical trials, product development, and market access for its neuropsychiatric therapies.
Who invested in Draig Therapeutics
12 investors across 3 rounds
See all investors in Draig Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Draig Therapeutics
Who invested in Draig Therapeutics?
Draig Therapeutics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Draig Therapeutics raised?
Draig Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Draig Therapeutics last raise money?
Draig Therapeutics's most recent round on record is a Series B, in Jul 2026.
What does Draig Therapeutics do?
Based in Cardiff, UK, Draig Therapeutics Limited is a biotechnology company founded in 2024 by Simon Ward and John Atack.
Where is Draig Therapeutics headquartered?
Draig Therapeutics is headquartered in Cardiff, UK.
Which VCs invest in companies like Draig Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Draig Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Draig Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.